SecBot SecBot
144 ·Filed Aug 20, 2026

NMRA

Neumora Therapeutics, Inc.
BEARISH
Impact 5/10
Horizondays Processed2mo ago SEC0001964306-26-000403
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

The director's repeated Form 144 filings over four consecutive days signal a deliberate monetization of equity awards. While the individual amounts are modest relative to market cap, the pattern warrants monitoring for further insider selling ahead of any upcoming catalysts or earnings. Traders should watch for additional Form 144 or Form 4 filings in the coming weeks.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$1.63
T+0 close · Aug 20, 2026 · via day close
Latest settled
−77.33%
T+60 · $0.3695
Vs SPY
−73.97%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 21 $1.63entry
  2. T+1 · 3mo ago −6.44%α −6.15% · $1.53
  3. T+5 · 3mo ago −14.72%α −15.20% · $1.39
  4. T+20 · 8w ago −57.56%α −57.03% · $0.6918
  5. T+60 · 20h ago −77.33%α −73.97% · $0.3695
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Daljit Singh Aurora filed a Form 144 notice to sell 134,452 shares (~$203,584) via a broker-assisted cashless exercise of employee stock options. This follows three prior sales by the same insider on Aug 17-19 totaling 277,773 shares (~$431,674), bringing the total proposed/executed sales to 412,225 shares (~$635,258) over four days.

Key Facts

  • Director Daljit Singh Aurora filed Form 144 to sell 134,452 shares at ~$203,584 via cashless option exercise.
  • This follows three prior sales on Aug 17-19 totaling 277,773 shares (~$431,674).
  • Total insider sales over four days: 412,225 shares (~$635,258).
  • Company market cap is $308M; the proposed sale alone represents ~0.07% of shares outstanding.
  • The filing is an advance notice of intent to sell; the sale may not occur, but the pattern of consecutive filings is notable.

Financial Impact

Proposed sale of 134,452 shares valued at ~$203,584; cumulative insider sales over four days ~$635,258.

dilution

Risk Factors

  • Insider selling may indicate lack of confidence in near-term prospects.
  • Cashless exercise of options suggests the insider is not retaining shares, reducing alignment with shareholders.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
80% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 2 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001964306-26-000403
Document: 0001964306-26-000403.txt0001964306-26-000403

Track record

14 reports on NMRA

Performance horizon

2 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +71.16% at T+60 after the Aug 17, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $0.3760 Now $0.3700 −1.60% settles Nov 24
  2. Nov 16, 2026today Press Release Neutral 4/10 Entry $0.4206 Now $0.3700 −12.03% settles Nov 23
  3. Oct 30, 202617d ago 8-K Bearish 7/10 Entry $0.4957 to $0.4859 Now $0.3700 +25.36% ▲ +1.98% +2.06% vs SPY
  4. Sep 22, 20267w ago Institutional Cluster Neutral 3/10 Entry $0.7785 to $0.6776 Now $0.3700 −52.47% ▼ −12.96% −11.77% vs SPY
  5. Aug 20, 202612w ago 144 Bearish 5/10 Viewing Entry $1.63 to $1.39 Now $0.3700 +77.30% ▲ +14.72% +15.20% vs SPY
  6. Aug 17, 202613w ago 144 Bearish 5/10 Entry $1.64 to $1.50 Now $0.3700 +77.44% ▲ +8.54% +8.34% vs SPY
  7. Aug 14, 202613w ago 8-K Neutral 4/10 No price data
  8. Aug 14, 202613w ago Press Release Neutral 4/10 Entry $1.60 to $1.63 Now $0.3700 −76.87% ▲ +1.88% +3.24% vs SPY
  9. Jul 27, 202616w ago 8-K Bullish 5/10 Entry $1.66 to $1.61 Now $0.3700 −77.71% ▼ −3.01% −4.09% vs SPY
  10. Jul 27, 202616w ago Press Release Bullish 7/10 Entry $1.66 to $1.61 Now $0.3700 −77.71% ▼ −3.01% −4.09% vs SPY
Showing 10 of 14

US Market Status

Market Closed · Opens in 6h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 20, 2026